IPA Conference-1999
International Pompe Association objectives to fulfill its mission.
Author: IPA
IPA Conferences
November 30, 1999
IPA Conference-1999
An overview of the first meeting of the International Pompe Association in Naarden, the Netherlands.
Author: IPA
IPA Conferences
November 30, 1999
IPA Conference-1999
Dr. A.J.J. Reuser, and Dr. A.T. van der Ploeg discuss the history of Pompe disease and the way...
Author: IPA
IPA Conferences
November 30, 1999
IPA Conference-1999
There are two main clinical variants of Pompe disease: The infantile form and the variant with late-onset.
Author: IPA
IPA Conferences
November 30, 1999
IPA Conference-1999
Epidemiological studies and prevalence of Pompe disease.
Author: IPA
IPA Conferences
November 30, 1999
IPA Conference-1999
Prof. Dr. J.J. Hopwood from Women’s and Children’s Hospital in Adelaide, Australia, discusses early diagnosis of Pompe disease.
Author: IPA
IPA Conferences
November 30, 1999
IPA Conference-1999
Representatives from Pharming and Genzyme discuss their joint venture and the collaboration with physicians, patients and their families.
Author: IPA
IPA Conferences
November 30, 1999
IPA Conference-1999
Dr. A. Amalfitano DO, PhD, from Duke University Medical Centre, discusses enzyme replacement therapy and the potential of...
Author: IPA
IPA Conferences
November 30, 1999
IPA Conference-1999
Dr. B. Devlin from Synpac (NC), Inc., USA discusses Synpac's commitment to bring a recombinant enzyme therapy for...
Author: IPA
IPA Conferences
November 30, 1999
IPA Conference-1999
Ms. M. Schoneveld van der Linde discusses the patient initiative to treatment for Pompe disease.
Author: IPA
IPA Conferences
November 30, 1999
1 2 3